EHC: Pangali EV/EBITDA Encompass Health Inc.

Demand for inpatient rehabilitation is rising due to the aging US population, which is increasing center occupancy rates for Encompass Health (EHC). This EV/EBITDA chart illustrates current valuation trends, where the value 11.35 characterizes this level. The expansion of the hospital network and a shortage of beds are stimulating growth, while centralized pharmaceutical procurement minimizes logistical risks, supporting high business profitability.

This metric combines market capitalization and net debt, comparing them against operating profit before taxes, depreciation, and amortization. The metric determines the real value of the business, identifying risks of a disconnect between borrowing growth and earnings. For Encompass Health, which is expanding capacity with low R&D expenditures, the 11.35 value reflects the efficiency of capital expenditures. The EV/EBITDA ratio dynamics, accounting for the capital structure, confirm the sustainability of the development model.